HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 06-07-2014, 06:56 PM   #10
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
Re: Fat Grafting

J Plast Surg Hand Surg. 2013 Sep;47(4):273-5. doi: 10.3109/2000656X.2012.759583. Epub 2013 Apr 30.
Autologous fat grafting and breast cancer recurrences: retrospective analysis of a series of 100 procedures in 64 patients.
Ihrai T1, Georgiou C, Machiavello JC, Chignon-Sicard B, Figl A, Raoust I, Bourgeon Y, Fouche Y, Flipo B.
Author information

Abstract
Autologous fat transfer (AFT) enhances the cosmetic results of breast reconstruction and corrects breast conserving operation sequelae. The question of its oncological safety remains, as in-vitro experiences have shown that adipocytes can stimulate cancer cell proliferation. This study analysed the records of patients who had AFT after breast cancer from 2004-2009. The primary end-point was cancer recurrence. The secondary end-points were AFT complications and post-AFT mammogram modifications. Sixty-four patients (100 AFT) were included. The mean follow-up for AFT was 46.44 months (SD = 21.4). Two breast cancer recurrences were recorded (3.1%). Among 55 mammograms analysed, only one patient presented radiological abnormalities. One complication of AFT (donor-site infection) was recorded. This series is in favour of the oncological safety of AFT after breast cancer. An accurate evaluation of the recurrence risk, before performing AFT, is an essential prerequisite and must lead one to postpone or avoid this procedure in high-risk patients.
PMID: 23627644 [PubMed - indexed for MEDLINE]
Lani is offline   Reply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 12:08 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter